Kamada Ltd. — Director's Dealing 2026

Apr 16, 2026

E

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5
1. Name and Address of Reporting Person Botzer Uri
---	---
(Last) (First) (Middle) 94 YIGAL ALON ST., ALON TOWER 2.
(Street) TEL AVIV 6789139
(City) (State) (Zip/Postal Code) ISRAEL
(Country)
Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	12/22/2023 (1)
Employee Stock Option (right to buy)	12/22/2024 (1)
Employee Stock Option (right to buy)	12/22/2025 (1)
Employee Stock Option (right to buy)	12/22/2026 (1)

Explanation of Responses:

1. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
2. All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 16, 2026.
3. The exercise price of the options was adjusted from $5.75 to $5.50 pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.
4. Held by trustee under the Company's 2011 Share Award Plan.

/S/ Uri Botzer

** Signature of Reporting Person

04/16/2026

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

---

EAL

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden hours per response	0.5

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person Asher-Topilsky Lilach		2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026	3. Issuer Name and Ticker or Trading Symbol KAMADA LTD [ KMDA ] 3a. Foreign Trading Symbol
(Last)	(First)
94 VIGAL ALON ST., ALON TOWER 2.			4. Relationship of Reporting Person(s) to Issuer (Check all applicable) ☑ Director 10% Owner Officer Other (give title specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
(Street)
TEL AVIV	6789139
(City)	(State)	(Zip/Postal Code)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting ☑ Person Form filed by More than One Reporting Person
ISRAEL
(Country)
Table I – Non-Derivative Securities Beneficially Owned
---	---	---	---	---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---	---	---	---	---
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	03/25/2021 (1)	09/25/2026	Ordinary Shares	6,625	$7.6(2)(3)
Employee Stock Option (right to buy)	03/25/2022 (1)	09/25/2026	Ordinary Shares	6,625	$7.6(2)(3)
Employee Stock Option (right to buy)	03/25/2023 (1)	09/25/2026	Ordinary Shares	6,625	$7.6(2)(3)
Employee Stock Option (right to buy)	12/22/2023 (1)	06/22/2029	Ordinary Shares	7,500	$6.17(2)(3)
Employee Stock Option (right to buy)	03/25/2024 (1)	09/25/2026	Ordinary Shares	6,625	$7.6(2)(3)
Employee Stock Option (right to buy)	12/22/2024 (1)	06/22/2029	Ordinary Shares	7,500	$6.17(2)(3)
Employee Stock Option (right to buy)	12/22/2025 (1)	06/22/2029	Ordinary Shares	7,500	$6.17(2)(3)
Employee Stock Option (right to buy)	12/22/2026 (1)	06/22/2029	Ordinary Shares	7,500	$6.17(2)(3)

Explanation of Responses:

1. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
2. All exercise prices presented in U.S. dollars represent a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of April 16, 2026.
3. The exercise price of the options was adjusted from $7.85 to $7.60 and from $6.42 to $6.17, respectively, pursuant to the provisions of the Company's 2011 Share Award Plan in connection with a cash dividend distribution declared by the Company's board of directors on March 11, 2026. There are no other changes to the terms and conditions of the option award.
4. Held by trustee under the Company's 2011 Share Award Plan.

/S/ Lilach Asher Topilsky

04/16/2026

---

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.